New treatment strategy tested for aggressive blood cancer
NCT ID NCT02896582
Summary
This study tested a multi-step treatment approach for adults with previously untreated mantle cell lymphoma, a type of blood cancer. Patients received chemotherapy combined with a targeted drug (obinutuzumab), followed by a stem cell transplant using their own cells. After the transplant, they received long-term maintenance therapy with the same drug for up to three years, with the goal of controlling the disease and preventing its return.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APHP - Hopital Necker
Paris, 75743, France
-
CH Perpignan
Perpignan, 66046, France
-
CH d'Avignon
Avignon, 84902, France
-
CHD Vendée
La Roche-sur-Yon, 85925, France
-
CHRU Bretonneau
Tours, 37044, France
-
CHRU Lille - Hôpital Claude Huriez
Lille, 59037, France
-
CHU Limoges
Limoges, 87042, France
-
CHU Lyon Sud
Pierre-Bénite, 69130, France
-
CHU Montpellier
Montpellier, 34295, France
-
CHU Nantes
Nantes, 44093, France
-
CHU Pontchaillou
Rennes, 35033, France
-
CHU Robert Debré
Reims, 51092, France
-
CHU d'Amiens
Amiens, 80480, France
-
CHU d'Angers
Angers, 49000, France
-
CHU de Brabois
Vandœuvre-lès-Nancy, France
-
CHU de Caen
Caen, 14033, France
-
CHU de Clermont Ferrand
Clermont-Ferrand, 63000, France
-
CHU de Dijon - Hôpital le Bocage
Dijon, 21034, France
-
CHU de Grenoble
Grenoble, 38700, France
-
CHU de Haut Leveque
Pessac, 33604, France
-
CHU de Poitiers
Poitiers, 86021, France
-
CHU de Strasbourg
Strasbourg, 67091, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Hospitalier Annecy-Genevois
Pringy, 74374, France
-
Clinique Victor Hugo
Le Mans, 72000, France
-
Gustave Roussy Cancer Campus
Villejuif, 94805, France
-
Hopital Henri Mondor
Créteil, 94010, France
-
Hôpital Saint Louis
Paris, 75475, France
-
I.U.C.T Oncopole
Toulouse, 31100, France
-
Institut de Cancérologie de Loire
Saint-Priest-en-Jarez, 42271, France
Conditions
Explore the condition pages connected to this study.